ID   DPEP1_HUMAN             Reviewed;         411 AA.
AC   P16444; D3DX80; Q96AK2;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 3.
DT   18-JUN-2025, entry version 233.
DE   RecName: Full=Dipeptidase 1;
DE            EC=3.4.13.19 {ECO:0000269|PubMed:2303490, ECO:0000269|PubMed:32325220, ECO:0000269|PubMed:6334084};
DE   AltName: Full=Beta-lactamase {ECO:0000305};
DE            EC=3.5.2.6 {ECO:0000269|PubMed:6334084};
DE   AltName: Full=Dehydropeptidase-I;
DE   AltName: Full=Microsomal dipeptidase {ECO:0000303|PubMed:2303490};
DE   AltName: Full=Renal dipeptidase {ECO:0000303|PubMed:8097406};
DE            Short=hRDP {ECO:0000303|PubMed:8097406};
DE   Flags: Precursor;
GN   Name=DPEP1; Synonyms=MDP {ECO:0000303|PubMed:2303490}, RDP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Liver;
RX   PubMed=8439558; DOI=10.1016/0167-4781(93)90289-p;
RA   Satoh S., Kusunoki C., Konta Y., Niwa M., Kohsaka M.;
RT   "Cloning and structural analysis of genomic DNA for human renal
RT   dipeptidase.";
RL   Biochim. Biophys. Acta 1172:181-183(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], CATALYTIC ACTIVITY, AND TISSUE SPECIFICITY.
RX   PubMed=2303490; DOI=10.1016/s0021-9258(19)39692-9;
RA   Adachi H., Tawaragi Y., Inuzuka C., Kubota I., Tsujimoto M., Nishihara T.,
RA   Nakazato H.;
RT   "Primary structure of human microsomal dipeptidase deduced from molecular
RT   cloning.";
RL   J. Biol. Chem. 265:3992-3995(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Kidney;
RX   PubMed=7764673; DOI=10.1021/bp00026a002;
RA   Satoh S., Ohtsuka K., Keida Y., Kusunoki C., Konta Y., Niwa M., Kohsaka M.;
RT   "Gene structural analysis and expression of human renal dipeptidase.";
RL   Biotechnol. Prog. 10:134-140(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   PROTEIN SEQUENCE OF 17-56; 111-121 AND 298-310.
RX   PubMed=2137335; DOI=10.1042/bj2650429;
RA   Hooper N.M., Keen J.N., Turner A.J.;
RT   "Characterization of the glycosyl-phosphatidylinositol-anchored human renal
RT   dipeptidase reveals that it is more extensively glycosylated than the pig
RT   enzyme.";
RL   Biochem. J. 265:429-433(1990).
RN   [8]
RP   PROTEIN SEQUENCE OF 17-39.
RX   PubMed=2768222; DOI=10.1093/oxfordjournals.jbchem.a122787;
RA   Adachi H., Kubota I., Okamura N., Iwata H., Tsujimoto M., Nakazato H.,
RA   Nishihara T., Noguchi T.;
RT   "Purification and characterization of human microsomal dipeptidase.";
RL   J. Biochem. 105:957-961(1989).
RN   [9]
RP   PROTEIN SEQUENCE OF 17-31.
RX   PubMed=15340161; DOI=10.1110/ps.04682504;
RA   Zhang Z., Henzel W.J.;
RT   "Signal peptide prediction based on analysis of experimentally verified
RT   cleavage sites.";
RL   Protein Sci. 13:2819-2824(2004).
RN   [10]
RP   CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=6334084; DOI=10.1016/s0021-9258(17)42642-1;
RA   Campbell B.J., Forrester L.J., Zahler W.L., Burks M.;
RT   "Beta-lactamase activity of purified and partially characterized human
RT   renal dipeptidase.";
RL   J. Biol. Chem. 259:14586-14590(1984).
RN   [11]
RP   GPI-ANCHOR AT SER-385, PROTEIN SEQUENCE OF 379-385, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=2168407; DOI=10.1016/s0021-9258(18)77261-x;
RA   Adachi H., Katayama T., Inuzuka C., Oikawa S., Tsujimoto M., Nakazato H.;
RT   "Identification of membrane anchoring site of human renal dipeptidase and
RT   construction and expression of a cDNA for its secretory form.";
RL   J. Biol. Chem. 265:15341-15345(1990).
RN   [12]
RP   MUTAGENESIS OF GLU-141, CATALYTIC ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=8097406; DOI=10.1016/0167-4838(93)90276-w;
RA   Adachi H., Katayama T., Nakazato H., Tsujimoto M.;
RT   "Importance of Glu-125 in the catalytic activity of human renal
RT   dipeptidase.";
RL   Biochim. Biophys. Acta 1163:42-48(1993).
RN   [13]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-57 AND ASN-279.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 17-385 IN COMPLEX WITH ZINC AND
RP   CILASTATIN, SUBUNIT, COFACTOR, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-57
RP   AND ASN-332.
RX   PubMed=12144777; DOI=10.1016/s0022-2836(02)00632-0;
RA   Nitanai Y., Satow Y., Adachi H., Tsujimoto M.;
RT   "Crystal structure of human renal dipeptidase involved in beta-lactam
RT   hydrolysis.";
RL   J. Mol. Biol. 321:177-184(2002).
RN   [15]
RP   VARIANT [LARGE SCALE ANALYSIS] HIS-246.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [16]
RP   INDUCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=28413640; DOI=10.3892/br.2017.870;
RA   Tachibana K., Saito M., Imai J.I., Ito E., Yanagisawa Y., Honma R.,
RA   Saito K., Ando J., Momma T., Ohki S., Ohtake T., Watanabe S., Waguri S.,
RA   Takenoshita S.;
RT   "Clinicopathological examination of dipeptidase 1 expression in colorectal
RT   cancer.";
RL   Biomed. Rep. 6:423-428(2017).
RN   [17]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF GLU-141, TISSUE SPECIFICITY,
RP   AND ACTIVITY REGULATION.
RX   PubMed=31442408; DOI=10.1016/j.cell.2019.07.017;
RA   Choudhury S.R., Babes L., Rahn J.J., Ahn B.Y., Goring K.R., King J.C.,
RA   Lau A., Petri B., Hao X., Chojnacki A.K., Thanabalasuriar A., McAvoy E.F.,
RA   Tabaries S., Schraeder C., Patel K.D., Siegel P.M., Kopciuk K.A.,
RA   Schriemer D.C., Muruve D.A., Kelly M.M., Yipp B.G., Kubes P., Robbins S.M.,
RA   Senger D.L.;
RT   "Dipeptidase-1 is an adhesion receptor for neutrophil recruitment in lungs
RT   and liver.";
RL   Cell 178:1205-1221(2019).
RN   [18]
RP   FUNCTION, TRANSPORTER ACTIVITY, MUTAGENESIS OF GLU-141 AND ASP-304, AND
RP   ZINC-BINDING.
RX   PubMed=32325220; DOI=10.1016/j.jsb.2020.107512;
RA   Hayashi K., Longenecker K.L., Koenig P., Prashar A., Hampl J., Stoll V.,
RA   Vivona S.;
RT   "Structure of human DPEP3 in complex with the SC-003 antibody Fab fragment
RT   reveals basis for lack of dipeptidase activity.";
RL   J. Struct. Biol. 211:107512-107512(2020).
CC   -!- FUNCTION: Hydrolyzes a wide range of dipeptides including the
CC       conversion of leukotriene D4 to leukotriene E4 (PubMed:2303490,
CC       PubMed:31442408, PubMed:32325220, PubMed:6334084). Hydrolyzes cystinyl-
CC       bis-glycine (cys-bis-gly) formed during glutathione degradation
CC       (PubMed:32325220). Also possesses beta lactamase activity and can
CC       hydrolyze the beta-lactam antibiotic imipenem (PubMed:32325220,
CC       PubMed:6334084). {ECO:0000250|UniProtKB:P31428,
CC       ECO:0000269|PubMed:2303490, ECO:0000269|PubMed:31442408,
CC       ECO:0000269|PubMed:32325220, ECO:0000269|PubMed:6334084}.
CC   -!- FUNCTION: Independently of its dipeptidase activity, acts as an
CC       adhesion receptor for neutrophil recruitment from bloodstream into
CC       inflamed lungs and liver. {ECO:0000250|UniProtKB:P31428}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an L-aminoacyl-L-amino acid + H2O = 2 an L-alpha-amino acid;
CC         Xref=Rhea:RHEA:48940, ChEBI:CHEBI:15377, ChEBI:CHEBI:59869,
CC         ChEBI:CHEBI:77460; EC=3.4.13.19; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10073, ECO:0000269|PubMed:2303490,
CC         ECO:0000269|PubMed:32325220};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=leukotriene D4 + H2O = leukotriene E4 + glycine;
CC         Xref=Rhea:RHEA:48616, ChEBI:CHEBI:15377, ChEBI:CHEBI:57305,
CC         ChEBI:CHEBI:57462, ChEBI:CHEBI:63166;
CC         Evidence={ECO:0000269|PubMed:2303490, ECO:0000269|PubMed:32325220};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a beta-lactam + H2O = a substituted beta-amino acid;
CC         Xref=Rhea:RHEA:20401, ChEBI:CHEBI:15377, ChEBI:CHEBI:35627,
CC         ChEBI:CHEBI:140347; EC=3.5.2.6;
CC         Evidence={ECO:0000269|PubMed:32325220, ECO:0000269|PubMed:6334084};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-cystine-bis-glycine + 2 H2O = L-cystine + 2 glycine;
CC         Xref=Rhea:RHEA:60520, ChEBI:CHEBI:15377, ChEBI:CHEBI:35491,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:143812;
CC         Evidence={ECO:0000269|PubMed:32325220};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=glycyldehydrophenylalanine + H2O = 2,3-didehydrophenylalanine
CC         + glycine; Xref=Rhea:RHEA:62704, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:57305, ChEBI:CHEBI:145925, ChEBI:CHEBI:145926;
CC         Evidence={ECO:0000269|PubMed:2303490, ECO:0000269|PubMed:31442408,
CC         ECO:0000269|PubMed:6334084};
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10073, ECO:0000269|PubMed:12144777};
CC       Note=Binds 2 Zn(2+) ion per monomer. {ECO:0000269|PubMed:12144777};
CC   -!- ACTIVITY REGULATION: Inhibited by L-penicillamine (PubMed:31442408).
CC       Beta-lactamase activity is inhibited by cilastatin (PubMed:31442408,
CC       PubMed:6334084). {ECO:0000269|PubMed:31442408,
CC       ECO:0000269|PubMed:6334084}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=10.9 uM for imipenem {ECO:0000269|PubMed:6334084};
CC         Vmax=44.5 umol/min/mg enzyme with imipenem as substrate
CC         {ECO:0000269|PubMed:6334084};
CC   -!- SUBUNIT: Homodimer; disulfide-linked. {ECO:0000255|PROSITE-
CC       ProRule:PRU10073, ECO:0000269|PubMed:12144777}.
CC   -!- INTERACTION:
CC       P16444; P16219: ACADS; NbExp=2; IntAct=EBI-749514, EBI-3904404;
CC       P16444; Q92624: APPBP2; NbExp=3; IntAct=EBI-749514, EBI-743771;
CC       P16444; Q96EK5: KIFBP; NbExp=2; IntAct=EBI-749514, EBI-744150;
CC   -!- SUBCELLULAR LOCATION: Apical cell membrane
CC       {ECO:0000269|PubMed:28413640}; Lipid-anchor, GPI-anchor
CC       {ECO:0000269|PubMed:2168407}. Cell projection, microvillus membrane
CC       {ECO:0000269|PubMed:2168407}; Lipid-anchor, GPI-anchor
CC       {ECO:0000269|PubMed:2168407}. Note=Brush border membrane.
CC       {ECO:0000250|UniProtKB:P31429}.
CC   -!- TISSUE SPECIFICITY: Expressed in lung and kidneys.
CC       {ECO:0000269|PubMed:31442408, ECO:0000269|PubMed:8439558}.
CC   -!- INDUCTION: Up-regulated in n colorectal cancers.
CC       {ECO:0000269|PubMed:28413640}.
CC   -!- SIMILARITY: Belongs to the metallo-dependent hydrolases superfamily.
CC       Peptidase M19 family. {ECO:0000255|PROSITE-ProRule:PRU10073}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D13137; BAA02430.1; -; Genomic_DNA.
DR   EMBL; J05257; AAB59410.1; -; mRNA.
DR   EMBL; D13138; BAA02431.1; -; mRNA.
DR   EMBL; S70330; AAC60630.2; -; Genomic_DNA.
DR   EMBL; S70329; AAC60630.2; JOINED; Genomic_DNA.
DR   EMBL; CH471184; EAW66719.1; -; Genomic_DNA.
DR   EMBL; CH471184; EAW66720.1; -; Genomic_DNA.
DR   EMBL; BC017023; AAH17023.1; -; mRNA.
DR   EMBL; BT006664; AAP35310.1; -; mRNA.
DR   CCDS; CCDS10982.1; -.
DR   PIR; S29848; S29848.
DR   RefSeq; NP_001121613.1; NM_001128141.3.
DR   RefSeq; NP_001376395.1; NM_001389466.1.
DR   RefSeq; NP_001376396.1; NM_001389467.1.
DR   RefSeq; NP_001376397.1; NM_001389468.1.
DR   RefSeq; NP_001376398.1; NM_001389469.1.
DR   RefSeq; NP_004404.1; NM_004413.4.
DR   RefSeq; XP_005256342.1; XM_005256285.4.
DR   RefSeq; XP_005256343.1; XM_005256286.3.
DR   RefSeq; XP_011521227.1; XM_011522925.2.
DR   RefSeq; XP_047289646.1; XM_047433690.1.
DR   RefSeq; XP_047289649.1; XM_047433693.1.
DR   RefSeq; XP_054235704.1; XM_054379729.1.
DR   RefSeq; XP_054235705.1; XM_054379730.1.
DR   PDB; 1ITQ; X-ray; 2.30 A; A/B=17-385.
DR   PDB; 1ITU; X-ray; 2.00 A; A/B=17-385.
DR   PDBsum; 1ITQ; -.
DR   PDBsum; 1ITU; -.
DR   AlphaFoldDB; P16444; -.
DR   SMR; P16444; -.
DR   BioGRID; 108134; 74.
DR   CORUM; P16444; -.
DR   FunCoup; P16444; 11.
DR   IntAct; P16444; 63.
DR   STRING; 9606.ENSP00000376807; -.
DR   BindingDB; P16444; -.
DR   ChEMBL; CHEMBL1989; -.
DR   DrugBank; DB01597; Cilastatin.
DR   DrugBank; DB06211; Doripenem.
DR   DrugBank; DB00303; Ertapenem.
DR   DrugBank; DB01598; Imipenem.
DR   DrugBank; DB00760; Meropenem.
DR   DrugBank; DB03424; Ubenimex.
DR   DrugCentral; P16444; -.
DR   MEROPS; M19.001; -.
DR   GlyConnect; 1174; 2 N-Linked glycans (1 site).
DR   GlyCosmos; P16444; 5 sites, 3 glycans.
DR   GlyGen; P16444; 6 sites, 139 N-linked glycans (4 sites), 2 O-linked glycans (2 sites).
DR   iPTMnet; P16444; -.
DR   PhosphoSitePlus; P16444; -.
DR   SwissPalm; P16444; -.
DR   BioMuta; DPEP1; -.
DR   DMDM; 92090943; -.
DR   jPOST; P16444; -.
DR   MassIVE; P16444; -.
DR   PaxDb; 9606-ENSP00000376807; -.
DR   PeptideAtlas; P16444; -.
DR   ProteomicsDB; 53362; -.
DR   Antibodypedia; 1973; 221 antibodies from 28 providers.
DR   DNASU; 1800; -.
DR   Ensembl; ENST00000261615.5; ENSP00000261615.4; ENSG00000015413.10.
DR   Ensembl; ENST00000393092.7; ENSP00000376807.3; ENSG00000015413.10.
DR   Ensembl; ENST00000421184.5; ENSP00000397313.1; ENSG00000015413.10.
DR   Ensembl; ENST00000690203.1; ENSP00000508584.1; ENSG00000015413.10.
DR   GeneID; 1800; -.
DR   KEGG; hsa:1800; -.
DR   MANE-Select; ENST00000690203.1; ENSP00000508584.1; NM_001389466.1; NP_001376395.1.
DR   UCSC; uc002fnr.5; human.
DR   AGR; HGNC:3002; -.
DR   CTD; 1800; -.
DR   DisGeNET; 1800; -.
DR   GeneCards; DPEP1; -.
DR   HGNC; HGNC:3002; DPEP1.
DR   HPA; ENSG00000015413; Group enriched (intestine, kidney, pancreas).
DR   MIM; 179780; gene.
DR   OpenTargets; ENSG00000015413; -.
DR   VEuPathDB; HostDB:ENSG00000015413; -.
DR   eggNOG; KOG4127; Eukaryota.
DR   GeneTree; ENSGT00940000159615; -.
DR   HOGENOM; CLU_031404_4_2_1; -.
DR   InParanoid; P16444; -.
DR   OMA; CDHPRNI; -.
DR   OrthoDB; 445695at2759; -.
DR   PAN-GO; P16444; 1 GO annotation based on evolutionary models.
DR   PhylomeDB; P16444; -.
DR   BioCyc; MetaCyc:HS00367-MONOMER; -.
DR   BRENDA; 3.4.13.19; 2681.
DR   PathwayCommons; P16444; -.
DR   Reactome; R-HSA-2142691; Synthesis of Leukotrienes (LT) and Eoxins (EX).
DR   Reactome; R-HSA-5423646; Aflatoxin activation and detoxification.
DR   Reactome; R-HSA-9664535; LTC4-CYSLTR mediated IL4 production.
DR   SABIO-RK; P16444; -.
DR   SignaLink; P16444; -.
DR   BioGRID-ORCS; 1800; 11 hits in 1162 CRISPR screens.
DR   ChiTaRS; DPEP1; human.
DR   EvolutionaryTrace; P16444; -.
DR   GeneWiki; Dipeptidase_1; -.
DR   GenomeRNAi; 1800; -.
DR   Pharos; P16444; Tclin.
DR   PRO; PR:P16444; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; P16444; protein.
DR   Bgee; ENSG00000015413; Expressed in ileal mucosa and 125 other cell types or tissues.
DR   ExpressionAtlas; P16444; baseline and differential.
DR   GO; GO:0045177; C:apical part of cell; IDA:UniProtKB.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; ISS:UniProtKB.
DR   GO; GO:0031528; C:microvillus membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0098552; C:side of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0008800; F:beta-lactamase activity; IDA:UniProtKB.
DR   GO; GO:0016805; F:dipeptidase activity; IDA:UniProtKB.
DR   GO; GO:0034235; F:GPI anchor binding; ISS:UniProtKB.
DR   GO; GO:0070573; F:metallodipeptidase activity; IDA:UniProtKB.
DR   GO; GO:0008235; F:metalloexopeptidase activity; TAS:UniProtKB.
DR   GO; GO:0072341; F:modified amino acid binding; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0016999; P:antibiotic metabolic process; IDA:UniProtKB.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0071732; P:cellular response to nitric oxide; ISS:UniProtKB.
DR   GO; GO:0006751; P:glutathione catabolic process; ISS:UniProtKB.
DR   GO; GO:0006749; P:glutathione metabolic process; TAS:UniProtKB.
DR   GO; GO:0050667; P:homocysteine metabolic process; IDA:UniProtKB.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0072340; P:lactam catabolic process; TAS:UniProtKB.
DR   GO; GO:1901749; P:leukotriene D4 catabolic process; IDA:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:UniProtKB.
DR   GO; GO:0030593; P:neutrophil chemotaxis; IEA:Ensembl.
DR   GO; GO:0006508; P:proteolysis; IEA:UniProtKB-KW.
DR   CDD; cd01301; rDP_like; 1.
DR   FunFam; 3.20.20.140:FF:000030; Dipeptidase; 1.
DR   Gene3D; 3.20.20.140; Metal-dependent hydrolases; 1.
DR   InterPro; IPR000180; Dipep_AS.
DR   InterPro; IPR032466; Metal_Hydrolase.
DR   InterPro; IPR008257; Pept_M19.
DR   PANTHER; PTHR10443:SF38; DIPEPTIDASE 1; 1.
DR   PANTHER; PTHR10443; MICROSOMAL DIPEPTIDASE; 1.
DR   Pfam; PF01244; Peptidase_M19; 1.
DR   SUPFAM; SSF51556; Metallo-dependent hydrolases; 1.
DR   PROSITE; PS00869; RENAL_DIPEPTIDASE_1; 1.
DR   PROSITE; PS51365; RENAL_DIPEPTIDASE_2; 1.
DR   neXtProt; NX_P16444; -.
DR   PharmGKB; PA144; -.
DR   TreeFam; TF324523; -.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Cell projection; Dipeptidase;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; GPI-anchor;
KW   Hydrolase; Lipid metabolism; Lipoprotein; Membrane; Metal-binding;
KW   Metalloprotease; Protease; Proteomics identification; Reference proteome;
KW   Signal; Zinc.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000269|PubMed:15340161,
FT                   ECO:0000269|PubMed:2137335, ECO:0000269|PubMed:2768222"
FT   CHAIN           17..385
FT                   /note="Dipeptidase 1"
FT                   /id="PRO_0000018652"
FT   PROPEP          386..411
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000269|PubMed:2168407"
FT                   /id="PRO_0000018653"
FT   BINDING         36
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10073,
FT                   ECO:0000269|PubMed:12144777"
FT   BINDING         38
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10073,
FT                   ECO:0000269|PubMed:12144777"
FT   BINDING         141
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10073,
FT                   ECO:0000269|PubMed:12144777, ECO:0000269|PubMed:32325220"
FT   BINDING         141
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10073,
FT                   ECO:0000269|PubMed:12144777, ECO:0000269|PubMed:32325220"
FT   BINDING         168
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:12144777"
FT   BINDING         214
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10073,
FT                   ECO:0000269|PubMed:12144777"
FT   BINDING         235
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /ligand_note="catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10073,
FT                   ECO:0000269|PubMed:12144777"
FT   BINDING         246
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:12144777"
FT   BINDING         304
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000269|PubMed:12144777"
FT   LIPID           385
FT                   /note="GPI-anchor amidated serine"
FT                   /evidence="ECO:0000269|PubMed:2168407"
FT   CARBOHYD        57
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12144777,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        279
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        332
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12144777"
FT   CARBOHYD        358
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        87..170
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10073,
FT                   ECO:0000269|PubMed:12144777"
FT   DISULFID        242..274
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10073,
FT                   ECO:0000269|PubMed:12144777"
FT   DISULFID        377
FT                   /note="Interchain"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10073,
FT                   ECO:0000269|PubMed:12144777"
FT   VARIANT         246
FT                   /note="R -> H (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs1043397364)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036496"
FT   VARIANT         351
FT                   /note="E -> K (in dbSNP:rs1126464)"
FT                   /id="VAR_061375"
FT   VARIANT         351
FT                   /note="E -> Q (in dbSNP:rs1126464)"
FT                   /id="VAR_061376"
FT   MUTAGEN         141
FT                   /note="E->A: Loss of zinc binding."
FT                   /evidence="ECO:0000269|PubMed:32325220"
FT   MUTAGEN         141
FT                   /note="E->C: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:8097406"
FT   MUTAGEN         141
FT                   /note="E->D: Abolished dipeptidase activity. Does not
FT                   affect ability to bind neutrophils."
FT                   /evidence="ECO:0000269|PubMed:31442408,
FT                   ECO:0000269|PubMed:8097406"
FT   MUTAGEN         141
FT                   /note="E->Q: Partial loss of activity."
FT                   /evidence="ECO:0000269|PubMed:8097406"
FT   MUTAGEN         304
FT                   /note="D->L: Loss of ability to hydrolyze
FT                   cystinyl-bis-glycine."
FT                   /evidence="ECO:0000269|PubMed:32325220"
FT   CONFLICT        9
FT                   /note="P -> S (in Ref. 1 and 3)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        102
FT                   /note="M -> R (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        125
FT                   /note="I -> R (in Ref. 2)"
FT                   /evidence="ECO:0000305"
FT   HELIX           18..27
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          32..37
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           39..47
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           54..56
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   TURN            58..60
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          63..65
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           68..73
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          76..83
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           87..89
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   TURN            90..93
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           94..111
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   TURN            113..115
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          116..118
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           122..131
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          134..141
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           143..146
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           150..158
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          161..166
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          168..170
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          173..175
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           178..180
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   TURN            181..183
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          188..192
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           194..206
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          209..211
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           217..226
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          232..235
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   TURN            239..241
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           250..259
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          262..265
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           269..272
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          274..276
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           280..294
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           296..298
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          299..301
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   TURN            305..307
FT                   /evidence="ECO:0007829|PDB:1ITQ"
FT   HELIX           321..330
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           335..342
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           344..356
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          359..361
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   HELIX           370..372
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   STRAND          375..377
FT                   /evidence="ECO:0007829|PDB:1ITU"
FT   TURN            381..383
FT                   /evidence="ECO:0007829|PDB:1ITU"
SQ   SEQUENCE   411 AA;  45674 MW;  C8C6474C3479D20D CRC64;
     MWSGWWLWPL VAVCTADFFR DEAERIMRDS PVIDGHNDLP WQLLDMFNNR LQDERANLTT
     LAGTHTNIPK LRAGFVGGQF WSVYTPCDTQ NKDAVRRTLE QMDVVHRMCR MYPETFLYVT
     SSAGIRQAFR EGKVASLIGV EGGHSIDSSL GVLRALYQLG MRYLTLTHSC NTPWADNWLV
     DTGDSEPQSQ GLSPFGQRVV KELNRLGVLI DLAHVSVATM KATLQLSRAP VIFSHSSAYS
     VCASRRNVPD DVLRLVKQTD SLVMVNFYNN YISCTNKANL SQVADHLDHI KEVAGARAVG
     FGGDFDGVPR VPEGLEDVSK YPDLIAELLR RNWTEAEVKG ALADNLLRVF EAVEQASNLT
     QAPEEEPIPL DQLGGSCRTH YGYSSGASSL HRHWGLLLAS LAPLVLCLSL L
//
